Who owns Immunovant (IMVT)? Superinvestor holders

3 superinvestors of the 157 tracked here hold Immunovant (IMVT) in their latest 13F filing, with $431.6M between them. Andrew Spokes gives it the most weight: 1.14% of the reported portfolio. In their latest reported quarter, Andrew Spokes added; Julian and Felix Baker reduced.

Hold it now
3
of 157 tracked
Combined value
$431.6M
Bought / sold
1 / 1
last quarter

Key facts

Superinvestors holding it
3 of 157
Biggest holder
Andrew Spokes, $218.6M
Largest weight
Andrew Spokes, 1.14%of their portfolio
Combined value
$431.6M
Bought last quarter
1
Sold last quarter
1

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding IMVT, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Andrew SpokesFarallon Capital Management1.14%$218.6M6.47M▲ Added 11%+665.85KQ3 2026
2Julian and Felix BakerBaker Bros. Advisors1.05%$209.4M5.44M▼ Reduced 0.4%−22.92KQ2 2026
3David EinhornGreenlight Capital0.09%$3.6M93.52KNo change0Q2 2026

Quarter by quarter

Superinvestor ownership of IMVT by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 20269216.47M$218.6M10
Q2 2026157311.33M$436.7M11
Q1 202615737.1M$176.3M21
Q4 202515725.47M$139M00
Q3 202515725.47M$88.2M00
Q2 202515725.47M$87.5M01
Q1 202515636.58M$112.5M11
Q4 202415633.13M$77.5M12

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of IMVT held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Andrew Spokes6.47M5.81M1.55M12K12K12K12K12K
Julian and Felix Baker·5.44M5.46M5.46M5.46M5.46M5.46M1.71M
David Einhorn·93.52K93.52K—————
Andreas Halvorsen·—————1.11M1.41M

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own IMVT?

In their latest 13F filings: Andrew Spokes (1.14% of the portfolio, $218.6M), Julian and Felix Baker (1.05% of the portfolio, $209.4M), David Einhorn (0.09% of the portfolio, $3.6M).

Who bought IMVT last quarter?

Andrew Spokes (added 11%). “Last quarter” is each investor's latest reported quarter.

Who sold IMVT last quarter?

Reduced: Julian and Felix Baker (0.4% fewer shares).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns Immunovant (IMVT)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/IMVT/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to IMVT by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.